A man is suing the manufacturers of Ozempic, alleging the diabetes drug caused him to go blind. The medication, containing semaglutide, works by regulating blood sugar and suppressing hunger. While ...

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...

Novo Nordisk hopes to expand Wegovy® label by becoming the first GLP-1 treatment for obesity in a pill <li /> The FDA filing i ...